Mandi L. Pratt-Chapman, PhD, associate center director for patient-centered initiatives and health equity at the George Washington University (GW) Cancer Center, recently attended the second National LGBTQ Cultural Competency Summit in Washington, D.C.
The George Washington University (GW) Cancer Center is pleased to announce the release of the Advancing Patient-Centered Cancer Survivorship Care Toolkit and a companion mini-module as part of the Cancer Survivorship E-Learning Series for Primary Care Providers.
Dr. Mikhail Kogan breaks down what the terms integrative, holistic and functional medicine mean.
WASHINGTON (Oct. 30, 2019) - November is Lung Cancer Awareness Month and according to the American Cancer Society, more than 220,000 new cases of lung cancer are diagnosed each year.
The Milken Institute School of Public Health (Milken Institute SPH) at the George Washington University (GW) today announced a $1.2 million grant from the National Institutes of Health (NIH) to examine the marketing strategies used by Philip Morris International to sell a new tobacco product…
National Postdoc Appreciation Week is an annual September event sponsored by the National Postdoctoral Association. In honor of National Postdoc Appreciation Week, the GW Cancer Center is proud to feature several of our talented postdoctoral researchers from across the University and Children's…
WASHINGTON (Sept. 24, 2019) - Breast cancer is the second most commonly diagnosed cancer in women in the United States, with the American Cancer Society predicting more than 250,000 new cases in 2019.
WASHINGTON (Sept. 24, 2019) - PTEN, a tumor suppressor gene mutated in approximately 20% of primary prostate cancers, and in as many as 50% of androgen deprivation-resistant prostate cancers, relies on another gene, ARID4B, to function.
Dr. Rengifo-Pardo is an accomplished dermatologist and clinical instructor of dermatology at the GW School of Medicine and Health Sciences. She also serves as clinical research coordinator at the GW Cancer Center.
WASHINGTON (Aug. 16, 2019) - The extracellular regulated kinase (ERK) protein is an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer, according to a study from a research team at the George Washington University (GW) Cancer Center.